These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25187119)

  • 1. Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial.
    Patel DV; Bolland M; Nisa Z; Al-Abuwsi F; Singh M; Horne A; Reid IR; McGhee CN
    Osteoporos Int; 2015 Feb; 26(2):499-503. PubMed ID: 25187119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of acute anterior uveitis after intravenous zoledronate.
    Patel DV; Horne A; House M; Reid IR; McGhee CN
    Ophthalmology; 2013 Apr; 120(4):773-6. PubMed ID: 23290982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Re-challenge in Patients with a History of Acute Anterior Uveitis Following Intravenous Zoledronate.
    Patel DV; Horne A; Mihov B; Stewart A; Reid IR; McGhee CN
    Calcif Tissue Int; 2015 Jul; 97(1):58-61. PubMed ID: 26001948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
    Moore MM; Beith JM
    Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis.
    Huang J; Meixner L; Fernandez S; McCutchan JA
    AIDS; 2009 Jan; 23(1):51-7. PubMed ID: 19050386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
    Umunakwe OC; Herren D; Kim SJ; Kohanim S
    Digit J Ophthalmol; 2017; 23(4):18-21. PubMed ID: 29403337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature.
    Jin X; Shou Z; Shao Y; Bian P
    Arch Osteoporos; 2021 Jun; 16(1):104. PubMed ID: 34180015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
    Chatterjee S; Agrawal D
    J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious ocular complications of zoledronate.
    Woo TC; Joseph DJ; Wilkinson R
    Clin Oncol (R Coll Radiol); 2006 Sep; 18(7):545-6. PubMed ID: 16969985
    [No Abstract]   [Full Text] [Related]  

  • 10. Zoledronic acid induced unilateral anterior uveitis.
    Gupta S; Onkar A; Vashisht T
    Indian J Ophthalmol; 2020 Sep; 68(9):2002-2003. PubMed ID: 32823458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fracture Prevention with Zoledronate in Older Women with Osteopenia.
    Reid IR; Horne AM; Mihov B; Stewart A; Garratt E; Wong S; Wiessing KR; Bolland MJ; Bastin S; Gamble GD
    N Engl J Med; 2018 Dec; 379(25):2407-2416. PubMed ID: 30575489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial.
    Reid IR; Horne AM; Mihov B; Stewart A; Garratt E; Wiessing KR; Bolland MJ; Bastin S; Gamble GD
    J Intern Med; 2019 Aug; 286(2):221-229. PubMed ID: 30887607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer.
    Jun JH
    Korean J Ophthalmol; 2017 Aug; 31(4):368-369. PubMed ID: 28682020
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial.
    Grey A; Bolland M; Wong S; Horne A; Gamble G; Reid IR
    J Clin Endocrinol Metab; 2012 Jan; 97(1):286-92. PubMed ID: 22072741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
    Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
    Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
    Belliveau MJ; Almeida DR; Urton TE
    Can J Ophthalmol; 2012 Oct; 47(5):e22-3. PubMed ID: 23036555
    [No Abstract]   [Full Text] [Related]  

  • 18. Zoledronate-induced anterior uveitis, scleritis and optic neuritis: a case report.
    Wolpert LE; Watts AR
    N Z Med J; 2021 Jun; 134(1537):91-94. PubMed ID: 34239165
    [No Abstract]   [Full Text] [Related]  

  • 19. Two case reports of zoledronic acid-induced uveitis.
    Kennedy T; Sellar PW; Vaideanu-Collins D; Ng J
    Age Ageing; 2018 Sep; 47(5):754-755. PubMed ID: 29718071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.
    Grey A; Bolland MJ; Horne A; Wattie D; House M; Gamble G; Reid IR
    Bone; 2012 Jun; 50(6):1389-93. PubMed ID: 22465268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.